Cost-effectiveness of cancer drugs is questioned

The widespread use of expensive cancer drugs to prolong patients’ lives by just weeks or months was called into question by an article published in the Journal of the National Cancer Institute. But while some policy experts consider the rationing of healthcare resources inevitable in the quest to control medical spending, many Americans have long resisted putting the collective fiscal good over their individual health.